RxSight (RXST) Shares Outstanding (2020 - 2026)

RxSight (RXST) has reported Shares Outstanding (Entity) for 7 consecutive years, with $41.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 1.64% year-over-year to $41.6 million; the trailing twelve-month figure through Jun 2026 stood at $41.6 million (up 1.64% YoY), and the FY2025 full-year result was $41.2 million, up 2.01% from the prior year.
• Shares Outstanding (Entity) steadied at $41.6 million in Q2 2026 per RXST's latest filing, from $41.4 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $41.6 million in Q2 2026 and bottomed at $27.5 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $36.5 million across 5 years, with a median of $38.4 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) soared 571.37% in 2022, then rose 1.64% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $28.3 million in 2022, then rose by 27.84% to $36.1 million in 2023, then rose by 11.87% to $40.4 million in 2024, then advanced by 2.01% to $41.2 million in 2025, then advanced by 0.83% to $41.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $41.6 million, $41.4 million, and $41.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.